Moreover, another study also demonstrated UCB-derived NK cells modified genetically by the novel TGFβ dominant-negative receptor exhibited higher cytotoxic activity against neuroblastoma in a TGFβ-rich environment in vitro and superior progression-free survival in mice, compared to unmodified controls. Here, TGFB1 is linked to neuroblastoma.